COVID-19 has impacted antimicrobial drug prescribing both directly, through COVID-19 treatment, and indirectly, through the reduced spread of illnesses for which antimicrobial drugs are commonly prescribed. This brief uses prescription claims data to explore trends in antimicrobial prescriptions dispensed from retail pharmacies as well as in long-term care facilities from 2019 to 2021, with the goal of understanding the impact of COVID-19 on antimicrobial prescribing during various phases of the pandemic and across different prescribing settings.
Related Products